Literature DB >> 19542133

Porphyromonas bennonis sp. nov., isolated from human clinical specimens.

Paula H Summanen1, Paul A Lawson, Sydney M Finegold.   

Abstract

During our investigation of the bacteriology of human wound infections and abscesses, a novel anaerobic, non-spore-forming, Gram-negative bacillus was frequently isolated. On the basis of morphological and biochemical criteria, the strains were tentatively identified as belonging to the family Bacteroidaceae, but they did not appear to correspond to any recognized species of this family. Comparative 16S rRNA gene sequencing showed that the 14 novel strains were genotypically homogeneous and confirmed their placement in the genus Porphyromonas. Sequence divergence values >10 % with respect to reference Porphyromonas species demonstrated that the strains isolated represent a novel species. On the basis of biochemical criteria and phylogenetic considerations, it is proposed that these strains isolated from human sources should be assigned to a novel species of the genus Porphyromonas, named Porphyromonas bennonis sp. nov., with WAL 1926C(T) (=ATCC BAA-1629(T) =CCUG 55979(T)) as the type strain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542133     DOI: 10.1099/ijs.0.001909-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  2 in total

1.  Comparative Genomics of the Genus Porphyromonas Identifies Adaptations for Heme Synthesis within the Prevalent Canine Oral Species Porphyromonas cangingivalis.

Authors:  Ciaran O'Flynn; Oliver Deusch; Aaron E Darling; Jonathan A Eisen; Corrin Wallis; Ian J Davis; Stephen J Harris
Journal:  Genome Biol Evol       Date:  2015-11-13       Impact factor: 3.416

2.  Genome-Based Taxonomic Classification of Bacteroidetes.

Authors:  Richard L Hahnke; Jan P Meier-Kolthoff; Marina García-López; Supratim Mukherjee; Marcel Huntemann; Natalia N Ivanova; Tanja Woyke; Nikos C Kyrpides; Hans-Peter Klenk; Markus Göker
Journal:  Front Microbiol       Date:  2016-12-20       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.